Dr. Mohamed Ghafir, MD
What this data tells you about Dr. Ghafir
Dr. Mohamed Ghafir is a radiation oncology specialist in Sugar Land, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ghafir performed 946 Medicare services across 671 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ghafir received a total of $501 from 12 pharmaceutical and/or device companies across 17 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ghafir is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 212 | $38 | $158 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 208 | $8 | $34 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 148 | $891 | $3,738 |
| Balloon dilation of dialysis segment with review by radiologist | 75 | $454 | $2,237 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 34 | $535 | $1,758 |
| Balloon dilation of vein with review by radiologist, initial vein | 32 | $1,029 | $4,561 |
| Review by radiologist of major upper body vein image | 31 | $92 | $420 |
| Injection, cefazolin sodium, 500 mg | 25 | $0 | $0 |
| Replacement of tunneled central venous tube | 23 | $326 | $2,360 |
| Prothrombin time test (blood clotting) | 22 | $4 | $25 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 22 | $122 | $220 |
| Ultrasonic guidance for blood vessel access | 21 | $30 | $98 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 20 | $17 | $60 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 19 | $77 | $212 |
| Balloon dilation of artery with review by radiologist, initial artery | 14 | $1,248 | $6,583 |
| Injection, diphenhydramine hcl, up to 50 mg | 14 | $0 | $0 |
| Removal of tunneled central venous tube | 13 | $73 | $434 |
| Insertion of needle and/or tube into hemodialysis circuit and insertion of stent in dialysis segment with review by radiologist | 13 | $3,291 | $17,143 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ghafir is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ghafir experienced with use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes?
Does Dr. Ghafir receive payments from pharmaceutical companies?
How do Dr. Ghafir's costs compare to other radiation oncologists in Sugar Land?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology